> Investors > 

News Releases

Date Title  
Toggle Summary ACETO Reports Fiscal 2019 First Quarter Results
PORT WASHINGTON, N.Y. , Nov. 08, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the
Printer Friendly Version
Toggle Summary ACETO Corporation Adopts Rights Plan Designed to Preserve Valuable Net Operating Loss Carryforwards and Other Tax Benefits
PORT WASHINGTON, N.Y. , Nov. 05, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET) today announced that its Board of Directors has adopted a tax asset protection rights plan (the “Rights Plan”).  The Rights Plan is designed to preserve ACETO’s net operating loss carryforwards (NOLs) and
Printer Friendly Version
Toggle Summary ACETO Corporation Schedules First Quarter & Fiscal 2019 Financial Results News Release and Conference Call
PORT WASHINGTON, N.Y. , Oct. 22, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ: ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of
Printer Friendly Version
Toggle Summary ACETO Reports Fiscal 2018 Fourth Quarter and Full-Year Results
Performance Chemicals and Pharmaceutical Ingredients Continue Strong Performance Repaid $43.2 Million of Debt During Fiscal Year 2018 PORT WASHINGTON, N.Y. , Sept. 28, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and
Printer Friendly Version
Toggle Summary ACETO Announces Credit Agreement Amendment
Will File Form 12b-25 to Extend Submission of Form 10-K Until September 28, 2018 On September 28, 2018 Company will Report Fourth Quarter & Fiscal 2018 Financial Results and Hold Earnings Conference Call Board of Directors Declares a Dividend of $0.01 per Share PORT WASHINGTON, N.Y. , Sept.
Printer Friendly Version
Toggle Summary ACETO Corporation Schedules Fourth Quarter & Fiscal 2018 Financial Results News Release and Conference Call
PORT WASHINGTON, N.Y. , Aug. 30, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ: ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of
Printer Friendly Version
Toggle Summary ACETO Subsidiary Acetris Health Receives Favorable Ruling Regarding Certain Government Contracts
PORT WASHINGTON, N.Y. , July 16, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that the United States
Printer Friendly Version
Toggle Summary Alan Levin Elected Chairman of the Board of Directors
Albert Eilender to Remain as Chairman Emeritus until Retiring at 2018 Annual Meeting PORT WASHINGTON, N.Y. , June 01, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products,
Printer Friendly Version
Toggle Summary ACETO Reports Fiscal 2018 Third Quarter Results
  Obtains a Waiver for Financial Covenants Generates Operating Cash Flows of $9.5 Million for the Third Quarter and $56.4 Million for the Nine-Months Ended March 31 , 2018  Board of Directors Declares a Dividend of $0.01 per Share PORT WASHINGTON, N.Y.
Printer Friendly Version
Toggle Summary ACETO Corporation Schedules Third Quarter Fiscal 2018 Financial Results News Release and Conference Call
PORT WASHINGTON, N.Y. , April 19, 2018 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, will issue its financial results of
Printer Friendly Version
top